Literature DB >> 27472400

Disproportionate longer-term opioid use among U.S. adults with mood disorders.

Brian T Halbert1, Roger B Davis1,2, Christina C Wee1.   

Abstract

Adults with mood disorders frequently use prescription opioids. The factors associated with this increased use remain unclear. We used the Medical Expenditure Panel Surveys from 2005 to 2011 to measure the association of mood disorders with new opioid use and the transition to longer-term opioid use for a variety of pain conditions before and after controlling for patient characteristics and clinical disability. We analyzed 33,450 adults with likely acute or potentially chronic pain conditions who were not using opioids at baseline. Among respondents with likely acute pain conditions, those with mood disorders initiated opioids more frequently for that pain condition compared with those without mood disorders (19.3%, vs 17.2%, P = 0.01). After initiation, they also transitioned to longer-term opioid therapy more frequently (11.7% vs 5.3%, P < 0.01). Among respondents with potentially chronic pain conditions, adults with mood disorders initiated opioid therapy more frequently for their chronic pain condition (11.5% vs 9.2%, P < 0.01) and transitioned to longer-term therapy more frequently (36.8% vs 19.9%, P < 0.01). After adjusting for sociodemographics and clinical disability, there was no association between mood disorders and new opioid use for likely acute (adjusted odds ratio [aOR] 1.05 [0.92-1.20]) or potentially chronic pain (aOR 0.91 [0.80-1.03]). However, there remained a strong association between mood disorders and the transition to longer-term opioid use for likely acute (aOR 1.77 [1.15-2.72]) and potentially chronic pain (aOR 1.95 [1.42-2.68]). Targeting the transition to longer-term opioid use may help clinicians reduce potentially inappropriate opioid prescriptions in this high-risk population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27472400      PMCID: PMC5069117          DOI: 10.1097/j.pain.0000000000000650

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  13 in total

1.  Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan.

Authors:  Karen H Seal; Ying Shi; Gregory Cohen; Beth E Cohen; Shira Maguen; Erin E Krebs; Thomas C Neylan
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

2.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

3.  Practical considerations on the use of the Charlson comorbidity index with administrative data bases.

Authors:  W D'Hoore; A Bouckaert; C Tilquin
Journal:  J Clin Epidemiol       Date:  1996-12       Impact factor: 6.437

Review 4.  What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose.

Authors:  Tamara M Haegerich; Leonard J Paulozzi; Brian J Manns; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2014-10-14       Impact factor: 4.492

5.  Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.

Authors:  Mark J Edlund; Bradley C Martin; Andrea Devries; Ming-Yu Fan; Jennifer Brennan Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2010-01       Impact factor: 3.442

6.  Emergency department visits among recipients of chronic opioid therapy.

Authors:  Jennifer Brennan Braden; Joan Russo; Ming-Yu Fan; Mark J Edlund; Bradley C Martin; Andrea DeVries; Mark D Sullivan
Journal:  Arch Intern Med       Date:  2010-09-13

7.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

8.  Trends in long-term opioid therapy for noncancer pain among persons with a history of depression.

Authors:  Jennifer Brennan Braden; Mark D Sullivan; G Thomas Ray; Kathleen Saunders; Joseph Merrill; Michael J Silverberg; Carolyn M Rutter; Constance Weisner; Caleb Banta-Green; Cynthia Campbell; Michael Von Korff
Journal:  Gen Hosp Psychiatry       Date:  2009-08-27       Impact factor: 3.238

Review 9.  Opioid therapy for chronic pain in the United States: promises and perils.

Authors:  Mark D Sullivan; Catherine Q Howe
Journal:  Pain       Date:  2013-09-11       Impact factor: 6.961

10.  Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates.

Authors:  Joseph A Boscarino; Stuart N Hoffman; John J Han
Journal:  Subst Abuse Rehabil       Date:  2015-08-19
View more
  23 in total

1.  Medical Use and Misuse of Prescription Opioids in the US Adult Population: 2016-2017.

Authors:  Pamela C Griesler; Mei-Chen Hu; Melanie M Wall; Denise B Kandel
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

2.  Opioid analgesic dependence: where do we go from here?

Authors:  Jane Quinlan; Farrukh Alam; Kyle Knox
Journal:  Br J Gen Pract       Date:  2017-04       Impact factor: 5.386

3.  Perioperative opioid use and misuse.

Authors:  Jane Quinlan; Sarah Rann; Ruth Bastable; Nicholas Levy
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

4.  Opioid Exposure Negatively Affects Antidepressant Response to Venlafaxine in Older Adults with Chronic Low Back Pain and Depression.

Authors:  Sarah T Stahl; Changgi Jung; Debra K Weiner; Marta Peciña; Jordan F Karp
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

5.  The association between depression and type of treatments received for chronic low back pain.

Authors:  Max Zubatsky; Matthew Witthaus; Jeffrey F Scherrer; Joanne Salas; Sarah Gebauer; Sandra Burge; F David Schneider
Journal:  Fam Pract       Date:  2020-07-23       Impact factor: 2.267

6.  A Population Study of Prescribed Opioid-based Pain Reliever Use among Individuals with Mood and Anxiety Disorders in Canada.

Authors:  Lisa J W Liu; Paxton Bach; James A G Crispo; John L K Kramer; Jacquelyn J Cragg
Journal:  Drug Alcohol Depend       Date:  2020-08-09       Impact factor: 4.492

7.  Poorer Physical and Mental Health Status Are Associated with Subsequent Opioid Prescriptions: a U.S. National Study.

Authors:  Anthony Jerant; Alicia Agnoli; Peter Franks
Journal:  J Gen Intern Med       Date:  2019-10-21       Impact factor: 5.128

8.  Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study.

Authors:  Justin S Liberman; Lucy D'Agostino McGowan; Robert A Greevy; James A Morrow; Marie R Griffin; Christianne L Roumie; Carlos G Grijalva
Journal:  Clin Rheumatol       Date:  2020-02-08       Impact factor: 2.980

9.  Patient and clinician incentives and barriers for opioid use for musculoskeletal disorders a qualitative study on opioid use in musculoskeletal setting.

Authors:  Anne-Britt E Dekker; Iris Kleiss; Nikita Batra; Matthew Seghers; Inger B Schipper; David Ring; Kasey Claborn
Journal:  J Orthop       Date:  2020-04-29

10.  Anxiety and Mood Disorders Impacting Physician Opioid Prescribing in the Pediatric Hospital Setting.

Authors:  Candice D Donaldson; Zeev N Kain; Louis Ehwerhemuepha; Michelle A Fortier; Michael T Phan; Daniel M Tomaszewski; Sun Yang; William Feaster; Brooke N Jenkins
Journal:  J Clin Psychol Med Settings       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.